Will Cannabis Seeds Be Restricted?
A redefinition of hemp under national law, scheduled to take place Nov. 12, signals the loss of Farm Bill safeguards for numerous hemp-derived THC items across the country: mild beverages as well as THCA bud and delta-8 THC gummies, vapes and additional products sold at gas stations and smoke shops.
But the hemp ban also creates a major complication for the legal cannabis industry. Seeds from cannabis cultivars that generate flower with greater than 0.3% THC are no longer legal to ship out of state.
Although seed buying will likely continue in authorized states, the modifications threaten to close some seed banks and genetics companies, observers say, while causing supply-chain issues for cannabis cultivators and retailers.
“If this wording goes forward, we will require pop-up shops to sell seeds in each state where it’s permitted,” Campanella said. “Which is why we’re also providing clones and tissue culture, because that’s not covered in the bill.”
When are cannabis seeds and clones prohibited to ship across state lines?
The new regulations categorize seeds based on the THC potential of the mother plant. Genetic material such as seeds and clones are made illegal if the end product exceeds the threshold.
For now, seeds are currently shipping under the 2018 Farm Bill’s current quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis cultivators who fear supply chain interruptions if out-of-state access to genetics is banned.
Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.
Without government intervention in the form of an exception for seeds or a general moratorium, many seed providers will simply be shuttered by November, he added.
“We are operating legally currently, but if that changes, it will disrupt the legitimate licensed industry in every state,” said Power, whose clientele includes seed banks as well as licensed business cultivators.
“Consumers are going to lose choice, and it will be a significant shutdown for most people.”
What are cannabis seed banks doing to remain legal after the government hemp ban?
Sagui Silber has already recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which tightened cannabis oversight in that state while also limiting hemp-derived THC items to licensed cannabis retailers.
Formerly a seed supplier, Silberhaze is now focused on the marketing, preservation and IP safeguarding of premium plant genetics.
That’s because seed companies hoping to remain compliant in this new environment must have airtight documentation, he said.
“You have to demonstrate where this material comes from, so it’s very important to have documentation, even to the extent where you have breeder names,” Silber said.
“Small businesses will have to operate with better records and a stronger chain of custody,” he added. “We need that documentation too, because we don’t want to be working with shady sources.”
To prevent seizures and other legal consequences, seed entrepreneurs must “get their ducks in a row” before the new regulations take effect, Silber said.
“Review all your stuff immediately, and classify what you can,” Silber said. “Take stock, document your lineage, preserve breeder records, and organize any cannabinoid or terpene data you currently have. If regulations change, you’ll be in a much better position to comprehend what may be impacted and make informed decisions.”
Does federal marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration licensing may be necessary for businesses engaged in research.
But for now, seed companies can’t register with the DEA like state-licensed therapeutic cannabis operators can. Such a pathway is not available to seed banks, nurseries or genetics businesses, said Jim Ickes, a lawyer and partner with Frantz Ward’s cannabis law group in Cleveland.
“Seed-related activity may be occurring inside broader state-licensed therapeutic marijuana businesses, as some states permit dispensaries or registered medical operators to sell seeds, clones or personal growing materials,” he said.
“But that is distinct from the DEA establishing a freestanding seed bank registration category.”
Some genetics companies are already changing business practices to comply with the updated law. According to Ickes, they must answer questions including:
- Which of our lines produce plants over 0.3% total THC?
- Which seeds survive as hemp after Nov. 12, 2026, and which don’t?
- What does our inventory look like once we sort it against the viable-seed exclusion?
Ickes also recognizes confusion from customers who believed federal rescheduling of therapeutic marijuana would resolve their situation with banking institutions. However, the latest regulatory language has moved those conversations beyond the basics of classification, he said.
“Financial institutions ask whether this particular revenue stream is legal, whether it connects to state-licensed operations, or whether there’s interstate-commerce risk,” said Ickes.
“After November, a seed supplier selling drug-type genetics can’t address the first question with the hemp definition. It has to refer to a legal state cannabis channel instead. Seed suppliers dealing in genuine industrial-hemp seed keep the simpler story.”
What’s the future of cannabis genetics?
Campanella is part of a new coalition of fellow breeders, farmers and researchers that’s arguing seeds are more appropriately defined as farm inputs than controlled substances. To that effect, seeds should be managed by the U.S. Department of Agriculture, https://nativesusa.com/ (nativesusa.com) allowing the DEA to focus its enforcement work elsewhere.
“How do you regulate something based on what it might become later?” said Campanella. “Our choice is to have that wording removed, or have seeds regulated by the USDA as a hemp product.”
But in the interim, Campanella is restructuring Brothers Grimm to function outside the reach of shifting federal oversight. The company plans to keep its Colorado seed operation while placing its Oklahoma tissue cultivation facility as a hedge against government prohibition of cannabis seeds.
As she noted: “If things develop in a way where we can’t focus on interstate transport, we’ll have other resources to satisfy people’s requirements without getting ourselves in trouble.”